An in-depth overview of enfortumab vedotin plus pembrolizumab, the newly approved treatment for advanced bladder cancer.
An in-depth overview of enfortumab vedotin plus pembrolizumab, the newly approved treatment for advanced bladder cancer.
As the holiday season approaches, there’s a special opportunity to spread joy while making a real impact.
This presentation provides an in-depth overview of non-muscle invasive bladder cancer, covering risk factors, diagnosis, and treatment options.
A presentation about the surgical management of bladder cancer including TURBT, bladder instillations and radical cystectomy.
An informative webinar exploring the various urinary diversions available to individuals undergoing a radical cystectomy.
Learn about the three most common types of urinary diversions used in Canada.
Our volunteers give their time, compassion, and dedication to support bladder cancer patients.
A comprehensive overview of bladder cancer, including risk factors, symptoms, diagnosis, staging, grading, and treatment options.
A new support group for anyone whose loved one has been affected by bladder cancer.
Join us on October 22 to learn more about how to navigate life with and beyond a bladder cancer diagnosis.
4936 Yonge Street, Suite 1000, Toronto, ON M2N 6S3
Phone: 1-866-674-8889
Email & Media Contact: info@bladdercancercanada.org
Privacy Policy | Donor Bill of Rights
Charitable Reg No. 83612 6060 RR0001
© Bladder Cancer Canada.